Revolution Medicines Inc

Revolution Medicines Inc

RVMD · NASDAQ
RVMD · NASDAQ
165.79
USD6.163.86%

Latest News

    @MarketRebels
    MarketRebels

    Revolution Medicines $RVMD **UOA** surged 30.66%  after a potential cancer drug, daraxonrasib, helped patients with advanced pancreatic cancer live longer. @petenajarian @jonnajarian #ITSNOTANOPTION 📙 https://t.co/6oURR2iuaJ

      @MarketRebels
      MarketRebels

      STARTS NOW Rebels Edge 1pm $RVMD $GS $FAST $BBY 🏈 NAJARIAN SPORTS 🏴‍☠️ with @petenajarian GOLF: Masters, Mcilroy was on fire Rory 2nd round was epic, he lead after every round NFL: Draft in 10 days 3 players that are moving up: Freeling, Thineman, Gentry #ITSNOTANOPTION 📙 https://t.co/UqitZZUz62

        SeekingAlpha

        Revolution Medicines plummets on report Merck walks from acquisition talks

          SeekingAlpha

          Revolution Medicines declines to comment on M&A speculation at conference

            SeekingAlpha

            Merck in talks to acquire Revolution Medicines for about $30B - WSJ

              SeekingAlpha

              Revolution Medicines soars on report Merck in talks to buy

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              160.22USD
              169.51USD

              52 Week Range

              69.50USD
              224.31USD

              Market Cap

              34.87BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US76155X1000

              CUSIP

              76155X100

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -

              Book Value

              11.11

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -9.13

              Wall Street Target Price

              274.68

              EPS Estimate Current Year

              -8.18

              EPS Estimate Next Year

              -2.72

              EPS Estimate Current Quarter

              -2.3813

              EPS Estimate Next Quarter

              -1.9767

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              197,559,008

              Gross Profit TTM

              -1,253,687,040

              EBITDA

              -1,675,138,944

              Profit Margin

              0.00%

              Return On Assets TTM

              -32.13%

              Return On Equity TTM

              -93.56%

              Revenue Per Share TTM

              0.965

              Qtly Revenue Growth YOY

              -95.20%

              Diluted Eps TTM

              -9.13

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              176.4856

              Price Book MRQ

              14.5185

              Enterprise Value Revenue

              161

              Enterprise Value EBITDA

              -9

              Peers analysis

              • argenx SE
                ARGNFargenx SE

                965.00

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                128.26

                0.00%
              • Be
                ONCBeOne Medicines AG

                390.94

                -2.36%
              • UCB SA ADR
                UCBJYUCB SA ADR

                151.52

                -2.31%
              • argenx NV ADR
                ARGXargenx NV ADR

                925.70

                -1.93%
              • CSL Ltd
                CSLLYCSL Ltd

                32.39

                -1.88%
              • UCB SA
                UCBJFUCB SA

                318.32

                -1.17%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                516.11

                -1.04%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                917.00

                -0.91%
              • Moderna Inc
                MRNAModerna Inc

                199.30

                -0.11%

              FAQs

              What is Revolution Medicines stock price today?

              What is Revolution Medicines stock ticker?

              Is RVMD stock price going up?

              What is the analyst recommendation for RVMD?

              What is RVMD market cap?

              Does RVMD release financial reports?

              When is RVMD next earnings date?

              What were RVMD Earnings for the last quarter?

              What was RVMD Revenue for the last quarter?

              What was RVMD Net Income for the last quarter?

              Does RVMD pay dividends?

              How many employees does RVMD have?

              What is RVMD EBITDA?

              How to buy RVMD stocks?

              Should I invest in RVMD stock?